Improved quality
Colin Kerr
Published: Thursday, February 1, 2018
Heidelberg Engineering presented the latest features of the SPECTRALIS OCT Angiography Module at the 5th International Congress on OCT Angiography in Rome, Italy.
“OCT angiography fully integrated in a multimodal imaging workflow is surely one of the most promising diagnostic tools in modern ophthalmic imaging. However, for clinicians to enjoy its benefits they need a device with resolution that is high enough to see capillary networks in detail and the ability to track eye movement and remove projection artifacts in a reliable manner”, said Dr Kester Nahen, Managing Director of Heidelberg Engineering.
The new features of the SPECTRALIS OCT Angiography Module include an improved image quality for the precise visualisation of pathology and structures in the deep vascular complex, a refined retinal layer segmentation and a unique projection artifact removal (PAR) tool. www.HeidelbergEngineering.com
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.